as of 09-25-2026 3:45pm EST
Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.
| Founded: | 1924 | Country: | United States |
| Employees: | N/A | City: | PARSIPPANY |
| Market Cap: | 279.9M | IPO Year: | 2021 |
| Target Price: | $18.50 | AVG Volume (30 days): | 1.1M |
| Analyst Decision: | Buy | Number of Analysts: | 2 |
| Dividend Yield: | Dividend Payout Frequency: | quarterly | |
| EPS: | 1.03 | EPS Growth: | 20.90 |
| 52 Week Low/High: | $2.77 - $14.91 | Next Earning Date: | 05-05-2026 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | 1.17% | Revenue Growth (next year): | -0.09% |
| P/E Ratio: | 5.46 | Index: | N/A |
| Free Cash Flow: | 182.4M | FCF Growth: | +612.11% |
Machine learning model trained on 25+ technical indicators
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Director
Avg Cost/Share
$5.88
Shares
6,293
Total Value
$36,971.38
Owned After
53,828.34
SEC Form 4
Director
Avg Cost/Share
$4.97
Shares
45,000
Total Value
$223,848.00
Owned After
109,587.208
SEC Form 4
Pres, Pharm Svc&Prod Mgmt, CLO
Avg Cost/Share
$4.99
Shares
20,000
Total Value
$99,800.00
Owned After
262,915.028
SEC Form 4
SVP and CFO
Avg Cost/Share
$4.67
Shares
20,000
Total Value
$93,360.00
Owned After
309,138.604
SEC Form 4
President and CEO
Avg Cost/Share
$4.70
Shares
30,000
Total Value
$140,937.00
Owned After
804,918.728
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Morris Milton Mayo | EMBC | Director | Sep 4, 2026 | Sell | $5.88 | 6,293 | $36,971.38 | 53,828.34 | |
| HOMBACH ROBERT J. | EMBC | Director | Aug 12, 2026 | Buy | $4.97 | 45,000 | $223,848.00 | 109,587.208 | |
| Mann Jeffrey Z | EMBC | Pres, Pharm Svc&Prod Mgmt, CLO | Aug 12, 2026 | Buy | $4.99 | 20,000 | $99,800.00 | 262,915.028 | |
| Elguicze Jacob | EMBC | SVP and CFO | Aug 12, 2026 | Buy | $4.67 | 20,000 | $93,360.00 | 309,138.604 | |
| Kurdikar Devdatt | EMBC | President and CEO | Aug 12, 2026 | Buy | $4.70 | 30,000 | $140,937.00 | 804,918.728 |
SEC 8-K filings with transcript text
Aug 7, 2026 · 100% conf.
1D
+5.30%
$4.65
Act: +12.90%
5D
+6.11%
$4.69
20D
+4.64%
$4.62
2 q32026ex-991.htm
Document
Embecta Corp. Reports Third Quarter Fiscal 2026 Financial Results
PARSIPPANY, N.J., Aug 7, 2026 (GLOBE NEWSWIRE) – Embecta Corp. (“embecta” or the "Company") (Nasdaq: EMBC), a global diabetes care company, today reported financial results for the three and nine month periods ended June 30, 2026.
"Our third quarter results improved significantly on a sequential basis, with revenue increasing approximately $50 million, GAAP operating income increasing approximately $14 million, and adjusted operating income increasing approximately $21 million as compared to our second quarter results. The sequential increase was due to a combination of factors, including improved performance within the United States and International, as well as contribution from the acquisition of Owen Mumford which closed mid-way through our third quarter," said Devdatt (Dev) Kurdikar, Chairman, President and Chief Executive Officer of embecta.
Mr. Kurdikar continued, "We repaid approximately $53 million of debt during the quarter and also repurchased approximately $9 million of shares under our three-year, up to $100 million share repurchase program. While our GLP-1 B2B partners launched generic GLP-1 therapies co-packaged with our pen needles in Canada and Brazil."
Mr. Kurdikar concluded, "Given our year-to-date performance, we are reaffirming our fiscal year revenue guidance range and raising our full year guidance ranges for adjusted operating margin and adjusted earnings per share."
Third Quarter Fiscal Year 2026 Financial Highlights:
•Reported revenues of $271.7 million, down 8.1% on a reported basis; down 8.9% on an adjusted constant currency basis
◦U.S. revenues decreased 24.6% on both a reported and adjusted constant currency basis
◦International revenues increased 11.5% on a reported basis, and 9.7% on an adjusted constant currency basis
•Gross profit and margin of $153.3 million and 56.4%, compared to $197.1 million and 66.7% in the prior year period
•Adjusted gross profit and margin of $158.0 million and 58.2%, compared to $198.6 million and 67.2% in the prior year period
•Operating income and margin of $48.7 million and 17.9%, compared to $94.0 million and 31.8% in the prior year period
•Adjusted operating income and margin of $69.4 million and 25.5%, compared to $109.1 million and 36.9% in the prior year period
•Net income and earnings per diluted share of $21.1 million and $0.36, compared to $45.5 million and $0.78 in the prior year period
•Adjusted net income and adjusted earnings per diluted share of $32.6 million and $0.56, compared to $65.5 million and $1.12 in the prior year period
•Adjusted EBITDA and margin of $85.7 million and 31.5%, compared to $131.0 million and 44.3% in the prior year period
•Announced a dividend of $0.01 per share
1
Nine Months Ended June 30 2026 Financial Highlights:
•Reported revenues of $754.7 million, down 7.6% on a reported basis; down 9.4% on an adjusted constant currency basis
◦U.S. revenues decreased 20.6% on both a reported and adjusted constant currency basis
◦International revenues increased 7.5% on a reported basis, and 3.6% on an adjusted constant currency basis
•Gross profit and margin of $442.8 million and 58.7%, compared to $518.3 million and 63.5% in the prior year period
•Adjusted gross profit and margin of $453.4 million and 60.1%, compared to $527.8 million and 64.6% in the prior year period
•Operating income and margin of $167.0 million and 22.1%, compared to $185.6 million and 22.7% in the prior year period
•Adjusted operating income and margin of $197.3 million and 26.1%, compared to $271.0 million and 33.2% in the prior year period
•Net income and earnings per diluted share of $61.1 million and $1.03, compared to $69.0 million and $1.18 in the prior year period
•Adjusted net income and adjusted earnings per diluted share of $91.0 million and $1.53, compared to $144.5 million and $2.46 in the prior year period
•Adjusted EBITDA and margin of $247.5 million and 32.8%, compared to $325.4 million and 39.9% in the prior year period
Strategic Highlights:
•Strengthen core business
◦Market-appropriate pen needles are progressing through regulatory review with the U.S. FDA and BSI for CE Mark certification
◦Market-appropriate syringe launches in certain geographies expected in the coming months
◦Completed brand transition in key European, Asian and Latin American markets and remain on track to be substantially complete by end of calendar year 2026
•Expand product portfolio
◦Completed the acquisition of Owen Mumford Holdings Limited ("Owen Mumford"); integration is progressing as planned
◦Continued to build on commercial momentum with the expansion of our B2B co-packaging opportunity, as generic GLP-1 therapies featuring embecta pen needles in the commercial packaging launched in Canada and Brazil, following the initial launch in India
◦Expect launch of GLP-1 small pack format in
May 5, 2026 · 100% conf.
1D
-2.05%
$3.91
Act: -10.78%
5D
-6.87%
$3.72
Act: -14.54%
20D
-12.20%
$3.50
Act: -16.79%
SEC.gov | Request Rate Threshold Exceeded
U.S. Securities and Exchange Commission
You’ve Exceeded the SEC’s Traffic Limit
Your request rate has exceeded the SEC’s maximum allowable requests per second. Your access to SEC.gov will be limited for 10 minutes.
Current guidelines limit each user to a total of no more than 10 requests per second, regardless of the number of machines used to submit requests. To ensure that SEC.gov remains available to all users, we reserve the right to block IP addresses that submit excessive requests.
The block will be lifted automatically by waiting 10 minutes. Continuing to exceed the SEC’s maximum allowable request rate during the time-out period will extend the duration of the time-out period. To ensure fair access for all users, please reduce the rate of your requests and visit SEC.gov again after the 10 minute time-out period has passed.
For best practices on efficiently downloading information from SEC.gov, including the latest EDGAR filings, visit sec.gov/developer. You can also sign up for email updates on the SEC open data program, including best practices that make it more efficient to download data, and SEC.gov enhancements that may impact scripted downloading processes. For more information, contact opendata@sec.gov.
For more information, please see the SEC’s Web Site Privacy and Security Policy. Thank you for your interest in the U.S. Securities and Exchange Commission.
Reference ID: 0.c706d217.1784725707.36140326
More Information
Internet Security Policy
By using this site, you are agreeing to security monitoring and auditing. For security purposes, and to ensure that the public service remains available to users, this government computer system employs programs to monitor network traffic to identify unauthorized attempts to upload or change information or to otherwise cause damage, including attempts to deny service to users.
Unauthorized attempts to upload information and/or change information on any portion of this site are strictly prohibited and are subject to prosecution under the Computer Fraud and Abuse Act of 1986 and the National Information Infrastructure Protection Act of 1996 (see Title 18 U.S.C. §§ 1001 and 1030).
To ensure our website performs well for all users, the SEC monitors the frequency of requests for SEC.gov content to ensure automated searches do not impact the ability of others to access SEC.gov content. We reserve the right to block IP addresses that submit excessive requests. Current guidelines limit users to a total of no more than 10 requests per second, regardless of the number of machines used to submit requests.
If a user or application submits more than 10 requests per second, further requests from the IP address(es) may be limited for a brief period. Once the rate of requests has dropped below the threshold for 10 minutes, the user may resume accessing content on SEC.gov. This SEC practice is designed to limit excessive automated searches on SEC.gov and is not intended or expected to impact individuals browsing the SEC.gov website.
Note that this policy may change as the SEC manages SEC.gov to ensure that the website performs efficiently and remains available to all users.
Note: We do not offer technical support for developing or debugging scripted downloading processes.
Feb 5, 2026 · 100% conf.
1D
-2.63%
$10.19
Act: +3.77%
5D
-7.11%
$9.73
Act: -4.49%
20D
-12.11%
$9.20
Act: -13.09%
embc-202602050001872789FALSE00018727892026-02-052026-02-05
Washington, D.C. 20549
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 5, 2026
(Exact name of registrant as specified in its charter)
Delaware (State or Other Jurisdiction of Incorporation)
001-4118687-1583942 (Commission File Number) (IRS Employer Identification No.)
300 Kimball Drive, Suite 300, Parsippany, New Jersey 07054 (Address of principal executive offices)(Zip Code)
Registrant’s telephone number, including area code: (862) 401-0000 N/A (Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Title of each classTrading symbol(s) Name of each exchange on which registered
Common Stock, par value $0.01 per shareEMBCThe Nasdaq Stock Market LLC (Nasdaq Global Select Market)
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02.Results of Operations and Financial Condition. On February 5, 2026, Embecta Corp. issued a press release (the “Press Release”) regarding its results for the quarter ended December 31, 2025. The Press Release is furnished as Exhibit 99.1 to this report.
Item 9.01.Financial Statements and Exhibits. (d)Exhibits The following is furnished as an exhibit to this report:
99.1 Press Release, dated February 5, 2026.
104Cover Page Interactive Data File (embedded within the Inline XBRL document)
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: February 5, 2026 By:/s/ Jacob Elguicze Jacob Elguicze Chief Financial Officer
Nov 25, 2025
embc-202511250001872789FALSE00018727892025-11-252025-11-25
Washington, D.C. 20549
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 25, 2025
(Exact name of registrant as specified in its charter)
Delaware (State or Other Jurisdiction of Incorporation)
001-4118687-1583942 (Commission File Number) (IRS Employer Identification No.)
300 Kimball Drive, Suite 300, Parsippany, New Jersey 07054 (Address of principal executive offices)(Zip Code)
Registrant’s telephone number, including area code: (862) 401-0000 N/A (Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Title of each classTrading symbol(s) Name of each exchange on which registered
Common Stock, par value $0.01 per shareEMBCThe Nasdaq Stock Market LLC (Nasdaq Global Select Market)
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02.Results of Operations and Financial Condition. On November 25, 2025, Embecta Corp. (the “Company”) issued a press release (the “Earnings Release”) regarding its results for the quarter and fiscal year ended September 30, 2025. The Earnings Release is furnished as Exhibit 99.1 to this report.
Item 9.01.Financial Statements and Exhibits. (d)Exhibits The following is furnished as an exhibit to this report:
99.1 Press Release, dated November 25, 2025.
104Cover Page Interactive Data File (embedded within the Inline XBRL document)
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: November 25, 2025 By:/s/ Jacob Elguicze Jacob Elguicze Chief Financial Officer
Aug 8, 2025
embc-202508080001872789FALSE00018727892025-08-082025-08-08
Washington, D.C. 20549
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 8, 2025
(Exact name of registrant as specified in its charter)
Delaware (State or Other Jurisdiction of Incorporation)
001-4118687-1583942 (Commission File Number) (IRS Employer Identification No.)
300 Kimball Drive, Suite 300, Parsippany, New Jersey 07054 (Address of principal executive offices)(Zip Code)
Registrant’s telephone number, including area code: (862) 401-0000 N/A (Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Title of each classTrading symbol(s) Name of each exchange on which registered
Common Stock, par value $0.01 per shareEMBCThe Nasdaq Stock Market LLC (Nasdaq Global Select Market)
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02.Results of Operations and Financial Condition. On August 8, 2025, Embecta Corp. issued a press release (the “Press Release”) regarding its results for the quarter ended June 30, 2025. The Press Release is furnished as Exhibit 99.1 to this report.
Item 9.01.Financial Statements and Exhibits. (d)Exhibits The following is furnished as an exhibit to this report:
99.1 Press Release, dated August 8, 2025.
104Cover Page Interactive Data File (embedded within the Inline XBRL document)
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: August 8, 2025 By:/s/ Jacob Elguicze Jacob Elguicze Chief Financial Officer
May 9, 2025
embc-202505090001872789FALSE00018727892025-05-092025-05-09
Washington, D.C. 20549
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 9, 2025
(Exact name of registrant as specified in its charter)
Delaware (State or Other Jurisdiction of Incorporation)
001-4118687-1583942 (Commission File Number) (IRS Employer Identification No.)
300 Kimball Drive, Suite 300, Parsippany, New Jersey 07054 (Address of principal executive offices)(Zip Code)
Registrant’s telephone number, including area code: (862) 401-0000 N/A (Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Title of each classTrading symbol(s) Name of each exchange on which registered
Common Stock, par value $0.01 per shareEMBCThe Nasdaq Stock Market LLC (Nasdaq Global Select Market)
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02.Results of Operations and Financial Condition. On May 9, 2025, Embecta Corp. issued a press release (the “Press Release”) regarding its results for the quarter ended March 31, 2025. The Press Release is furnished as Exhibit 99.1 to this report.
Item 9.01.Financial Statements and Exhibits. (d)Exhibits The following is furnished as an exhibit to this report:
99.1 Press Release, dated May 9, 2025.
104Cover Page Interactive Data File (embedded within the Inline XBRL document)
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: May 9, 2025 By:/s/ Jacob Elguicze Jacob Elguicze Chief Financial Officer
Feb 6, 2025
embc-202502060001872789FALSE00018727892025-02-062025-02-06
Washington, D.C. 20549
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 6, 2025
(Exact name of registrant as specified in its charter)
Delaware (State or Other Jurisdiction of Incorporation)
001-4118687-1583942 (Commission File Number) (IRS Employer Identification No.)
300 Kimball Drive, Suite 300, Parsippany, New Jersey 07054 (Address of principal executive offices)(Zip Code)
Registrant’s telephone number, including area code: (862) 401-0000 N/A (Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Title of each classTrading symbol(s) Name of each exchange on which registered
Common Stock, par value $0.01 per shareEMBCThe Nasdaq Stock Market LLC (Nasdaq Global Select Market)
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02.Results of Operations and Financial Condition. On February 6, 2025, Embecta Corp. issued a press release (the “Press Release”) regarding its results for the quarter ended December 31, 2024. The Press Release is furnished as Exhibit 99.1 to this report.
Item 9.01.Financial Statements and Exhibits. (d)Exhibits The following is furnished as an exhibit to this report:
99.1 Press Release, dated February 6, 2025.
104Cover Page Interactive Data File (embedded within the Inline XBRL document)
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: February 6, 2025 By:/s/ Jacob Elguicze Jacob Elguicze Chief Financial Officer
Nov 26, 2024
embc-202411260001872789FALSE00018727892024-11-262024-11-26
Washington, D.C. 20549
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 26, 2024
(Exact name of registrant as specified in its charter)
Delaware (State or Other Jurisdiction of Incorporation)
001-4118687-1583942 (Commission File Number) (IRS Employer Identification No.)
300 Kimball Drive, Suite 300, Parsippany, New Jersey 07054 (Address of principal executive offices)(Zip Code)
Registrant’s telephone number, including area code: (862) 401-0000 N/A (Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Title of each classTrading symbol(s) Name of each exchange on which registered
Common Stock, par value $0.01 per shareEMBCThe Nasdaq Stock Market LLC (Nasdaq Global Select Market)
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02.Results of Operations and Financial Condition. On November 26, 2024, Embecta Corp. (the “Company”) issued a press release (the “Earnings Release”) regarding its results for the quarter and fiscal year ended September 30, 2024. The Earnings Release is furnished as Exhibit 99.1 to this report.
Item 2.05.Costs Associated with Exit or Disposal Activities. On November 22, 2024, the Company’s Board of Directors approved a plan to discontinue internal and external investment in the research and development of its patch pump program. The Company will refocus its investment on its core business with the intent to optimize free cash flow and strengthen its balance sheet by paying down debt. As a result of this decision, the Company plans to undergo an organizational restructuring (the "Restructuring Plan"). In addition, the Company intends to discontinue its plans to manufacture and commercialize the insulin delivery system, including the previous intended limited launch. The Company estimates that it will incur approximately $25 million - $30 million in pre-tax cash-based charges primarily associated with employee severance payments and benefits related to the workforce reduction. The Company also expects that the majority of the restructuring charges related to the workforce reduction will be incurred in the first quarter of fiscal 2025 and that the implementation of the workforce reduction, including cash payments, will be substantially complete by the end of the second quarter of fiscal year 2025. Additionally, the Company estimates that it will incur approximately $10 million - $15 million of additional pre-tax non-cash charges related to asset impairments and asset write-offs. However, the Company has not yet completed its analysis of the expected additional pre-tax non-cash charges associated with the implementation of the Restructuring Plan. Investors should note that the estimates of the pre-tax cash charges and additional charges that the Company expects to incur in connection with the Restructuring Plan, and the timing thereof, are subject to a number of assumptions and actual amounts may differ materially from estimates. In addition, the Company may incur other pre-tax cash charges or additional charges not currently contemplated due to unanticipated events that may occur, including in connection with the implementation of the Restructuring Plan.
This Current Report on Form 8-K contains express or implied “forward-looking statements” as that term is defined in the Private Securities Litigation Reform Act of 1995 and other securities laws. These forward-looking statements concern the Company’s current expectations regarding its future results from operations, performance, financial condition, goals, strategies, plans and achievements. These forward-looking statements are subject to various known and unknown risks, uncertainties and other factors,
Aug 9, 2024
embc-202408090001872789FALSE00018727892024-08-092024-08-09
Washington, D.C. 20549
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 9, 2024
(Exact name of registrant as specified in its charter)
Delaware (State or Other Jurisdiction of Incorporation)
001-4118687-1583942 (Commission File Number) (IRS Employer Identification No.)
300 Kimball Drive, Suite 300, Parsippany, New Jersey 07054 (Address of principal executive offices)(Zip Code)
Registrant’s telephone number, including area code: (862) 401-0000 N/A (Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Title of each classTrading symbol(s) Name of each exchange on which registered
Common Stock, par value $0.01 per shareEMBCThe Nasdaq Stock Market LLC (Nasdaq Global Select Market)
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02.Results of Operations and Financial Condition. On August 9, 2024, Embecta Corp. issued a press release (the “Press Release”) regarding its results for the quarter ended June 30, 2024. The Press Release is furnished as Exhibit 99.1 to this report.
Item 9.01.Financial Statements and Exhibits. (d)Exhibits The following is furnished as an exhibit to this report:
99.1 Press Release, dated August 9, 2024.
104Cover Page Interactive Data File (embedded within the Inline XBRL document)
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: August 9, 2024 By:/s/ Jacob Elguicze Jacob Elguicze Chief Financial Officer
May 9, 2024
embc-202405090001872789FALSE00018727892024-05-092024-05-09
Washington, D.C. 20549
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 9, 2024
(Exact name of registrant as specified in its charter)
Delaware (State or Other Jurisdiction of Incorporation)
001-4118687-1583942 (Commission File Number) (IRS Employer Identification No.)
300 Kimball Drive, Suite 300, Parsippany, New Jersey 07054 (Address of principal executive offices)(Zip Code)
Registrant’s telephone number, including area code: (862) 401-0000 N/A (Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Title of each classTrading symbol(s) Name of each exchange on which registered
Common Stock, par value $0.01 per shareEMBCThe Nasdaq Stock Market LLC (Nasdaq Global Select Market)
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02.Results of Operations and Financial Condition. On May 9, 2024, Embecta Corp. issued a press release (the “Press Release”) regarding its results for the quarter ended March 31, 2024. The Press Release is furnished as Exhibit 99.1 to this report.
Item 9.01.Financial Statements and Exhibits. (d)Exhibits The following is furnished as an exhibit to this report:
99.1 Press Release, dated May 9, 2024.
104Cover Page Interactive Data File (embedded within the Inline XBRL document)
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: May 9, 2024 By:/s/ Jacob Elguicze Jacob Elguicze Chief Financial Officer
Feb 9, 2024
embc-202402090001872789FALSE00018727892024-02-092024-02-09
Washington, D.C. 20549
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 9, 2024
(Exact name of registrant as specified in its charter)
Delaware (State or Other Jurisdiction of Incorporation)
001-4118687-1583942 (Commission File Number) (IRS Employer Identification No.)
300 Kimball Drive, Suite 300, Parsippany, New Jersey 07054 (Address of principal executive offices)(Zip Code)
Registrant’s telephone number, including area code: (862) 401-0000 N/A (Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Title of each classTrading symbol(s) Name of each exchange on which registered
Common Stock, par value $0.01 per shareEMBCThe Nasdaq Stock Market LLC (Nasdaq Global Select Market)
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02.Results of Operations and Financial Condition. On February 9, 2024, Embecta Corp. (the “Company” or "embecta") issued a press release (the “Earnings Release”) regarding its results for the quarter ended December 31, 2023. The Earnings Release is included as Exhibit 99.1 to this report.
Item 9.01.Financial Statements and Exhibits. (d)Exhibits The following is furnished as an exhibit to this report:
99.1 Press Release, dated February 9, 2024.
104Cover Page Interactive Data File (embedded within the Inline XBRL document)
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: February 9, 2024 By:/s/ Jacob Elguicze Jacob Elguicze Chief Financial Officer
Nov 21, 2023
embc-202311210001872789FALSE00018727892023-11-212023-11-21
Washington, D.C. 20549
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 21, 2023
(Exact name of registrant as specified in its charter)
Delaware (State or Other Jurisdiction of Incorporation)
001-4118687-1583942 (Commission File Number) (IRS Employer Identification No.)
300 Kimball Drive, Suite 300, Parsippany, New Jersey 07054 (Address of principal executive offices)(Zip Code)
Registrant’s telephone number, including area code: (862) 401-0000 N/A (Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Title of each classTrading symbol(s) Name of each exchange on which registered
Common Stock, par value $0.01 per shareEMBCThe Nasdaq Stock Market LLC (Nasdaq Global Select Market)
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02.Results of Operations and Financial Condition. On November 21, 2023, Embecta Corp. (the “Company” or "embecta") issued a press release (the “Earnings Release”) regarding its results for the quarter and fiscal year ended September 30, 2023. The Earnings Release is furnished as Exhibit 99.1 to this report.
Item 7.01.Regulation FD Disclosure. On November 21, 2023, the Company posted a presentation regarding diabetes market considerations to its website at https://investors.embecta.com/news-events/presentations (the "Diabetes Presentation"). A copy of the Diabetes Presentation is furnished as Exhibit 99.2 to this report.
Item 9.01.Financial Statements and Exhibits. (d)Exhibits The following is furnished as an exhibit to this report:
99.1 Press Release, dated November 21, 2023.
99.2
104Cover Page Interactive Data File (embedded within the Inline XBRL document)
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: November 21, 2023 By:/s/ Jacob Elguicze Jacob Elguicze Chief Financial Officer
Aug 8, 2023
embc-202308080001872789FALSE00018727892023-08-082023-08-08
Washington, D.C. 20549
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 8, 2023
(Exact name of registrant as specified in its charter)
Delaware (State or Other Jurisdiction of Incorporation)
001-4118687-1583942 (Commission File Number) (IRS Employer Identification No.)
300 Kimball Drive, Suite 300, Parsippany, New Jersey 07054 (Address of principal executive offices)(Zip Code)
Registrant’s telephone number, including area code: (862) 401-0000 N/A (Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Title of each classTrading symbol(s) Name of each exchange on which registered
Common Stock, par value $0.01 per shareEMBCThe Nasdaq Stock Market LLC (Nasdaq Global Select Market)
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02.Results of Operations and Financial Condition. On August 8, 2023, Embecta Corp. (the “Company” or "embecta") issued a press release (the “Earnings Release”) regarding its results for the quarter ended June 30, 2023. The Earnings Release is included as Exhibit 99.1 to this report.
Item 9.01.Financial Statements and Exhibits. (d)Exhibits The following is furnished as an exhibit to this report:
99.1 Press Release, dated August 8, 2023.
104Cover Page Interactive Data File (embedded within the Inline XBRL document)
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: August 8, 2023 By:/s/ Jacob Elguicze Jacob Elguicze Chief Financial Officer
May 12, 2023
embc-202305120001872789FALSE00018727892023-05-122023-05-12
Washington, D.C. 20549
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 12, 2023
(Exact name of registrant as specified in its charter)
Delaware (State or Other Jurisdiction of Incorporation)
001-4118687-1583942 (Commission File Number) (IRS Employer Identification No.)
300 Kimball Drive, Suite 300, Parsippany, New Jersey 07054 (Address of principal executive offices)(Zip Code)
Registrant’s telephone number, including area code: (862) 401-0000 N/A (Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Title of each classTrading symbol(s) Name of each exchange on which registered
Common Stock, par value $0.01 per shareEMBCThe Nasdaq Stock Market LLC (Nasdaq Global Select Market)
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02.Results of Operations and Financial Condition. On May 12, 2023, Embecta Corp. (the “Company” or "embecta") issued a press release (the “Earnings Release”) regarding its results for the quarter ended March 31, 2023. The Earnings Release is included as Exhibit 99.1 to this report.
Item 9.01.Financial Statements and Exhibits. (d)Exhibits The following is furnished as an exhibit to this report:
99.1 Press Release, dated May 12, 2023.
104Cover Page Interactive Data File (embedded within the Inline XBRL document)
Signature Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
By:/s/ Jacob Elguicze Jacob Elguicze Chief Financial Officer
Dated: May 12, 2023
Feb 14, 2023
embc-202302140001872789FALSE00018727892023-02-142023-02-14
Washington, D.C. 20549
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 14, 2023
(Exact name of registrant as specified in its charter)
Delaware (State or Other Jurisdiction of Incorporation)
001-4118687-1583942 (Commission File Number) (IRS Employer Identification No.)
300 Kimball Drive, Suite 300, Parsippany, New Jersey 07054 (Address of principal executive offices)(Zip Code)
Registrant’s telephone number, including area code: (862) 401-0000 N/A (Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Title of each classTrading symbol(s) Name of each exchange on which registered
Common Stock, par value $0.01 per shareEMBCThe Nasdaq Stock Market LLC (Nasdaq Global Select Market)
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02.Results of Operations and Financial Condition. On February 14, 2023, Embecta Corp. (the “Company” or "embecta") issued a press release (the “Earnings Release”) regarding its results for the quarter ended December 31, 2022. The Earnings Release is included as Exhibit 99.1 to this report.
Item 9.01.Financial Statements and Exhibits. (d)Exhibits The following is furnished as an exhibit to this report:
99.1 Press Release, dated February 14, 2023.
104Cover Page Interactive Data File (embedded within the Inline XBRL document)
Signature Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
By:/s/ Jacob Elguicze Jacob Elguicze Chief Financial Officer
Dated: February 14, 2023
Dec 20, 2022
embc-202212200001872789FALSE00018727892022-12-202022-12-20
Washington, D.C. 20549
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 20, 2022
(Exact name of registrant as specified in its charter)
Delaware (State or Other Jurisdiction of Incorporation)
001-4118687-1583942 (Commission File Number) (IRS Employer Identification No.)
300 Kimball Drive, Parsippany, New Jersey 07054 (Address of principal executive offices)(Zip Code)
Registrant’s telephone number, including area code: (201) 847-6880 N/A (Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Title of each classTrading symbol(s) Name of each exchange on which registered
Common Stock, par value $0.01 per shareEMBCThe Nasdaq Stock Market LLC (Nasdaq Global Select Market)
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02.Results of Operations and Financial Condition. On December 20, 2022, Embecta Corp. (the “Company” or "embecta") issued a press release (the “Earnings Release”) regarding its results for the quarter and fiscal year ended September 30, 2022. The Earnings Release is furnished as Exhibit 99.1 to this report.
Item 9.01.Financial Statements and Exhibits. (d)Exhibits The following is furnished as an exhibit to this report:
99.1 Press Release, dated December 20, 2022.
104Cover Page Interactive Data File (embedded within the Inline XBRL document)
Signature Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
By:/s/ Jacob Elguicze Jacob Elguicze Chief Financial Officer
Dated: December 20, 2022
Aug 15, 2022
embc-202208150001872789FALSE00018727892022-08-152022-08-15
Washington, D.C. 20549
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 15, 2022
(Exact name of registrant as specified in its charter)
Delaware (State or Other Jurisdiction of Incorporation)
001-4118687-1583942 (Commission File Number) (IRS Employer Identification No.)
300 Kimball Drive, Parsippany, New Jersey 07054 (Address of principal executive offices)(Zip Code)
Registrant’s telephone number, including area code: (201) 847-6880 N/A (Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Title of each classTrading symbol(s) Name of each exchange on which registered
Common Stock, par value $0.01 per shareEMBCThe Nasdaq Stock Market LLC (Nasdaq Global Select Market)
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02.Results of Operations and Financial Condition. On August 15, 2022, Embecta Corp. (the “Company” or "embecta") issued a press release (the “Earnings Release”) regarding its results for the quarter ended June 30, 2022. The Earnings Release is included as Exhibit 99.1 to this report.
Item 9.01.Financial Statements and Exhibits. (d)Exhibits The following is furnished as an exhibit to this report:
99.1 Press Release, dated August 15, 2022.
104Cover Page Interactive Data File (embedded within the Inline XBRL document)
Signature Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
By:/s/ Jacob Elguicze Jacob Elguicze Chief Financial Officer
Dated: August 15, 2022
May 13, 2022
embc-202205130001872789FALSE00018727892022-05-132022-05-13
Washington, D.C. 20549
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 13, 2022
(Exact name of registrant as specified in its charter)
Delaware (State or Other Jurisdiction of Incorporation)
001-4118687-1583942 (Commission File Number) (IRS Employer Identification No.)
300 Kimball Drive, Parsippany, New Jersey 07054 (Address of principal executive offices)(Zip Code)
Registrant’s telephone number, including area code: (201) 847-6880 N/A (Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Title of each classTrading symbol(s) Name of each exchange on which registered
Common Stock, par value $0.01 per shareEMBCThe Nasdaq Stock Market LLC (Nasdaq Global Select Market)
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02.Results of Operations and Financial Condition. On May 13, 2022, Embecta Corp. (the “Company” or "embecta") issued a press release (the “Earnings Release”) regarding its results for the quarter ended March 31, 2022. The Earnings Release is included as Exhibit 99.1 to this report.
Item 7.01.Regulation FD Disclosure. In connection with the conference call announced in the Earnings Release on May 13, 2022, the Company made available the Company Information Presentation furnished with this Current Report on Form 8-K as Exhibit 99.2 (the “Investor Presentation”) and available on the Company's website, www.embecta.com, relating to, among other things, its financial results for the quarter ended March 31, 2022. The Company expects to use the Investor Presentation, in whole or in part, and possibly with immaterial modifications, in connection with presentations to investors, analysts and others during the fiscal year ending September 30, 2022.
Item 9.01.Financial Statements and Exhibits. (d)Exhibits The following is furnished as an exhibit to this report:
99.1 Press Release, dated May 13, 2022.
99.2 Company Information Presentation ("Investor Presentation")
104Cover Page Interactive Data File (embedded within the Inline XBRL document)
Signature Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
By:/s/ Jacob Elguicze Jacob Elguicze Chief Financial Officer
Dated: May 13, 2022
3
See how EMBC stacks up against similar companies in the market
Enhance your trading experience with our free tools
The information presented on this page, "EMBC Embecta Corp. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.